Invention Grant
- Patent Title: Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
-
Application No.: US14918514Application Date: 2015-10-20
-
Publication No.: US10668084B2Publication Date: 2020-06-02
- Inventor: Wayne Kreppner , Siobhan Fogarty , Werner Oberegger , Paul José Pierre Marie Maes
- Applicant: Acerus Biopharma Inc.
- Applicant Address: CA Mississauga
- Assignee: Acerus Biopharma Inc.
- Current Assignee: Acerus Biopharma Inc.
- Current Assignee Address: CA Mississauga
- Agency: Lewis Brisbois Bisgaard & Smith LLP
- Agent Peter Manso; Howard M. Gitten
- Main IPC: A61K31/568
- IPC: A61K31/568 ; A61K9/00 ; A61K9/06 ; A61K9/127
Abstract:
The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
Public/Granted literature
Information query
